Dalong Cao - Concepedia

Author

Dalong Cao

Fudan University Shanghai Cancer Center

Also Known As

Cao, Da-Long, Cao, Dalong, Da-Long Cao, Da-long Cao, Dalong Cao, Da‐Long Cao

Publications

805

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Shanghai Jiao Tong University XinHua Hospital First Affiliated Hospital of Soochow University

About

Dalong Cao is an author at Fudan University Shanghai Cancer Center specializing in tumor biology, molecular diagnostics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	60
2	Pathology	2	2	60
3	Engineering	1	1	49
4	Biostatistics	1	1	49
5	Cell Biology	1	1	49

Dalong Cao

Publications

668

Citations

H-Index

Page 1

	Year	Citations
Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer Dalong Cao, Zihao Qi, Yangyang Pang, Cancer Research	2019	152
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population Yuanyuan Qu, Jinwen Feng, Xiaohui Wu, Nature Communications	2022	137
A multiplex model of combining gene‐based, protein‐based, and metabolite‐based with positive and negative markers in urine for the early diagnosis of prostate cancer Dalong Cao, Dingwei Ye, Hai‐Liang Zhang, The Prostate	2010	93
Proteogenomic characterization of MiT family translocation renal cell carcinoma Yuanyuan Qu, Xiaohui Wu, Aihetaimujiang Anwaier, Nature Communications	2022	67
Large‐scale transcriptome profiles reveal robust 20‐signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma Wenhao Xu, Yue Xu, Xi Tian, Journal of Cellular and Molecular Medicine EngineeringPathologyCcrcc TissuesMetabolic RemodelingCancer Biology	2020	49
Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data Xi Tian, Wenhao Xu, Yuchen Wang, OncoImmunology	2020	49
Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response Xi Tian, Wenhao Xu, Fujiang Xu, Annals of Medicine	2022	26
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor Hailiang Zhang, Lin Bai, Xinqiang Wu, Nature Communications	2023	26
Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma Yuanyuan Qu, Zhenmei Yao, Ning Xu, Cell Reports Medicine	2023	21
Identification and validation of novel metastasis-related signatures of clear cell renal cell carcinoma using gene expression databases. Chunguang Ma, Wenhao Xu, Yue Xu, PubMed	2020	13

Page 1